Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Conference News ESC 2025

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Michael O'Riordan

August 31, 2025

Presentation ESC 2025

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

Presenter: Faiez Zannad

August 30, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

Presentation TCT India 2025

Role of Vericiguat in Worsening Heart Failure

Presenter: J.P.S. Sawhney

July 26, 2025

Presentation THT Abstracts 2025

Effect of Vericiguat on Pulmonary Artery Pressures in Heart Failure Patients: Insights From Pressure Sensor Monitoring

Presenter: Boaz Elad

February 11, 2025

Presentation THT Abstracts 2025

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

February 11, 2025

Presentation THT 2025

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Presenter: Boaz Elad

February 11, 2025

Presentation THT 2025

Effect of Vericiguat on Pulmonary Artery Pressures in Heart Failure Patients: Insights From Pressure Sensor Monitoring

Presenter: Boaz Elad

February 11, 2025

Presentation THT 2023

Beyond the Four Foundational Therapies: Vericiguat and Omecamtiv Mecarbil

Presenter: John Teerlink

March 20, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

Even When Eligible, Not All Acute HF Patients Get GDMT

Todd Neale

January 11, 2023

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

Presentation THT 2022

Vericiguat

Presenter: Javed Butler

February 01, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

News Conference News ESC 2021

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

Shelley Wood

August 28, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Conference News ACC 2020

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

Michael O'Riordan

March 28, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

Advertisement

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

What’s Going to Be Hot at ESC Congress 2025?

Role of Vericiguat in Worsening Heart Failure

Effect of Vericiguat on Pulmonary Artery Pressures in Heart Failure Patients: Insights From Pressure Sensor Monitoring

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Effect of Vericiguat on Pulmonary Artery Pressures in Heart Failure Patients: Insights From Pressure Sensor Monitoring

Beyond the Four Foundational Therapies: Vericiguat and Omecamtiv Mecarbil

Vast Majority of HFrEF Patients Eligible for Vericiguat

Even When Eligible, Not All Acute HF Patients Get GDMT

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Vericiguat

TCTMD’s Top 10 Most Popular Stories for September 2021

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

FDA Approves Vericiguat for High-risk Patients With HF

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content